A Randomized, Double-blind, Placebo-controlled Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Study of Administrating Single Ascending Dose of HMS5552 in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2015
At a glance
- Drugs Sinogliatin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Hua Medicine
- 09 Jun 2015 Results of pooled analysis of two phase I trials presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 19 Mar 2014 Results were reported in a Hua Medicine media release.
- 19 Mar 2014 Results will be presented at the American Diabetes Association Conference according to a Hua Medicine media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History